3-methylhistidine
- Human trial5
- Humans2
- Animals2
Interventions
3Urolithin A
no changein humans1
1 study
Urolithin A
no changein humans1
Urolithin A has no effect on 3-methylhistidine in humans (Δ = -3.20 ± 0.31 μmol/L, p = 0.36).
“When compared to the placebo group, there was no significant difference observed in 3-MH in the UA group (Δ=-3.20 ± 0.31 μmol/L, p = 0.36).”
Human trial1 g daily8 weeksmales
Journal of the International Society of Sports Nutrition
Exercise
upin humans1
1 study
Exercise
upin humans1
Exercise increases 3-methylhistidine in humans.
“The urinary excretion levels of creatinine, 3-methylhistidine (3-MH), aldosterone, and catecholamines, and the 3-MH/creatinine ratio were significantly increased only during the exercise regimen.”
Human trial5 daysmalesn = 6
Heliyon
Creatine
downin humans1
1 study
Creatine
downin humans1
Creatine decreases 3-methylhistidine in humans (-40% vs +29% PLA, P < 0.05).
“Subjects receiving creatine (C and CP) experienced a decrease in 3-MH by 40% compared with an increase of 29% for PLA (P < 0.05)”
Human trialduring resistance training10 wkmales
Low-dose creatine combined with protein during resistance training in older men
Medicine and science in sports and exercise
Associations
1Type 2 diabetes
upin humans1
1 study
Type 2 diabetes
upin humans1
Type 2 diabetes is associated with 3-methylhistidine in humans.
“Older adults with F-T2DM showed an amino acid profile characterized by higher levels of 3-methylhistidine, alanine, arginine, ethanolamine, and glutamic acid.”
Humansfrail/pre-frail with type 2 diabetes mellitusn = 66
Metabolites
Latest
1 paper in 12 monthsJournal of Diabetes Investigation
Protective association of renin-angiotensin system inhibitor use with skeletal muscle wasting in diabetic heart failure
Cross-sectional study of 384 peopleHeart failure
Journal of the International Society of Sports Nutrition
Assessment of Urolithin A effects on muscle endurance, strength, inflammation, oxidative stress, and protein metabolism in male athletes with resistance training: an 8-week randomized, double-blind, placebo-controlled study
Randomized trial in 20 peopleUrolithin A
Metabolites
Amino Acid Profiles in Older Adults with Frailty: Secondary Analysis from MetaboFrail and BIOSPHERE Studies
Cross-sectional study in peopleBiomarkers
Journal of Cachexia, Sarcopenia and Muscle
Frailty is characterized by biomarker patterns reflecting inflammation or muscle catabolism in multi-morbid patients
Study in peopleBiomarkers